Sat Kartar Life Limited (NSE:SATKARTAR)
141.20
+6.70 (4.98%)
At close: Nov 6, 2026
Sat Kartar Life Revenue
Sat Kartar Life had revenue of 1.14B INR in the half year ending September 30, 2026. This brings the company's total for the last twelve months to 2.24B. In the fiscal year ending March 31, 2026, Sat Kartar Life had annual revenue of 2.01B with 23.19% growth. That makes Sat Kartar Life the 32,760th largest company in the world by revenue and 2,456th in India.
Revenue (ttm)
2.24B
Revenue Growth
+23.19%
P/S Ratio
0.99
Revenue / Employee
3.64M
Employees
617
Market Cap
2.22B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.01B | 377.74M | 23.19% |
| Mar 31, 2025 | 1.63B | 350.12M | 27.37% |
| Mar 31, 2024 | 1.28B | 449.40M | 54.16% |
| Mar 31, 2023 | 829.70M | 306.62M | 58.62% |
| Mar 31, 2022 | 523.07M | 233.69M | 80.75% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 8.38B |
| Ambalal Sarabhai Enterprises | 2.06B |
| Everest Organics | 1.92B |
| Gennex Laboratories | 1.78B |
| Kerala Ayurveda | 1.36B |
| Oxygenta Pharmaceutical | 1.35B |
| Accretion Pharmaceuticals | 1.01B |
| BDH Industries | 997.10M |